General Catalyst

General Catalyst is a venture capital firm established in 2000, headquartered in Cambridge, Massachusetts, with additional offices in North America and Europe. The company specializes in early-stage and growth equity investments, focusing on technology-driven businesses. It invests across various sectors, including consumer internet, enterprise software, fintech, health assurance, and crypto. General Catalyst provides not only capital but also mentorship and resources to accelerate the growth of its portfolio companies. To date, it has managed eight venture capital funds, totaling approximately $3.75 billion in capital commitments.

Adrian Abeijon

Investor

Mark Allen

CFO

Juliet Bailin

Partner

Jim Baum

General Catalyst

Marc Bhargava

Managing Director

Chris Bischoff

Managing Director

Larry Bohn

Managing Director

Kristen Camarota

Investor

Teresa Carlson

President, General Catalyst Institute

Kenneth Chenault

Managing Director

Quentin Clark

Managing Director

Mark Crane

Partner

Joel Cutler

Managing Director

Judith Dada

Partner

Christopher Davis

Partner

Kyle Doherty

Managing Director

David Fialkow

Managing Director

Molly Blaauw Gillis

Partner

Julia Goodman

Investor

Drew Gordon

Investor

Philipp Handel

Partner

Steve Herrod

Managing Director

Tony Ho

Investor

Diana Hong

Investor

Scott Howell

Advisor

Mina Hsiang

Associate

Nmachi Jidenma

Partner

Christopher Kauffman

Principal and Member of the Investment Team

Genevieve Kinney

Investor

Zak Kukoff

Principal

Paul Kwan

Managing Director

Roy Mabrey

Partner, Investment Team

Holly Maloney McConnell

Managing Director

Karanveer Mohan

Managing Director

Alexandre Momeni

Partner

Dipchand Nishar

Managing Director

Deep Nishar

Managing Director

Reva Nohria

Principal

Trevor Oelschig

Managing Director

Tyler Olkowski

Investor

Pranay Orugunta

Healthcare Investor

Mo Punjwani

Associate, Investments

Candace Richardson

Principal

Max Rimpel

Partner

Brian Ru

Principal

Paul Sagan

Investor

Pranav Singhvi

Partner

Bill Skarinka

Associate

Vedant Suri

Investor

Hemant Taneja

Managing Director

Alexander Tran

Managing Director, Investments

Catherine Tu

Partner

Adam Valkin

Managing Director

Elena Viboch

Partner

Andrea Wang

Partner

Zeynep Yavuz

Partner

Vincent Zhu

Investor

Jeannette zu Fürstenberg

Managing Director

Nathaniel Levy-Westhead

Partner, Investment Team

Samuel Beyer

Investor

Past deals in Health Diagnostics

Sohar Health

Seed Round in 2025
Sohar Health is a technology company that specializes in behavioral health solutions. It provides an API-based platform designed to streamline eligibility verification and utilize AI-powered medical coding to automate manual workflows. This automation helps to increase patient intake and generate more revenue for healthcare providers. The platform offers tools for secure file management, utilization analytics, and reporting, enabling digital health providers to scale their operations efficiently.

Fay

Series B in 2025
Fay is a company focused on enhancing individual health through better nutrition by connecting clients with dietitians who are covered by their health insurance. It offers consulting services that specialize in medical nutrition therapy, facilitating access to personalized dietary guidance. Fay assists clients in selecting a suitable dietitian, coordinating both virtual and in-person consultations, and developing tailored nutrition plans. Additionally, the company collaborates with insurance providers to ensure that these services are affordable and accessible, thereby enabling individuals to receive comprehensive nutrition counseling that aligns with their health needs.

Neko Health

Series B in 2025
Neko Health is a Swedish health-tech company focused on transforming healthcare through prevention and early detection. The company has developed innovative medical scanning technology that facilitates comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By utilizing advanced sensor technology and artificial intelligence, Neko Health aims to enhance preventive care and reduce the incidence of common diseases, thereby lowering associated healthcare costs. This approach enables healthcare providers to deliver flexible and cost-effective examinations, ultimately improving the quality of care and emphasizing the importance of preventive health measures.

Hippocratic AI

Series B in 2025
Hippocratic AI is a developer of safety-focused large language models designed for non-diagnostic, patient-facing applications within the healthcare sector. The company emphasizes the importance of evidence-based healthcare content, distinguishing itself from typical models that rely on a broader range of internet data, which may include inaccuracies. By prioritizing the acquisition of reliable healthcare information, Hippocratic AI aims to enhance healthcare accessibility and improve health outcomes. Its platform facilitates the delivery of healthcare services, allowing patients to receive care at home and manage their health more effectively and conveniently.

Orange Health Labs

Venture Round in 2024
Orange Health is a health technology company that facilitates remote diagnostic lab services for patients, allowing doctors to provide real-time care. Its platform focuses on patient-centric home sample collection and testing, aiming to make healthcare more accessible and efficient.

Oasys Now

Seed Round in 2024
Oasys Now is a platform dedicated to connecting chronic patients with relevant clinical trials worldwide. It uses advanced algorithms to match patients with appropriate trials based on their health data, enhancing treatment options and prioritizing patient privacy.

Ladder

Debt Financing in 2024
Ladder is a strength training app that provides a workout plan, every single day. Fitness-seekers can access a complete strength training program on their phone, learn from an expert coach, and engage with a community that shares a passion for fitness. The company is based in Austin, Texas.

Maven Clinic

Series F in 2024
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Doccla

Series B in 2024
Doccla provides virtual ward services that move care from hospital to home through remote monitoring. A tech-agnostic partner to care organisations, it enables early discharge and reduces hospital readmissions by remotely monitoring patients with devices. Services include at-home onboarding with monitoring equipment, supported by a mobile team of nurses and doctors who conduct ongoing monitoring and manage offboarding as patients recover, delivering higher quality care at lower cost. The Covid-19 support service originated from NHS research and is deployed in collaboration with Northampton General Hospital.

Better Health

Series A in 2024
Better Health is a digital platform facilitating peer-to-peer support and supplies management for individuals with chronic conditions such as ostomy, wounds, diabetes, retention, and incontinence. Trusted by major healthcare payers and providers, it improves patient outcomes and reduces care costs through education, engagement, and adherence.

Fay

Series A in 2024
Fay is a company focused on enhancing individual health through better nutrition by connecting clients with dietitians who are covered by their health insurance. It offers consulting services that specialize in medical nutrition therapy, facilitating access to personalized dietary guidance. Fay assists clients in selecting a suitable dietitian, coordinating both virtual and in-person consultations, and developing tailored nutrition plans. Additionally, the company collaborates with insurance providers to ensure that these services are affordable and accessible, thereby enabling individuals to receive comprehensive nutrition counseling that aligns with their health needs.

Hona AI

Seed Round in 2024
Hona AI is an AI data platform that collects and maintains healthcare history and records of patients.

Transcarent

Series D in 2024
Transcarent is a consumer-directed health and care platform serving employees of self-insured employers and their families. It combines software, technology, health guides, and data science to provide unbiased information, trusted guidance, and access to high-value care. The company connects users with an integrated ecosystem of high-value providers and health services, enabling customers to exercise choice and transparency for addressing a broad range of healthcare challenges.

Karius

Series C in 2024
Karius is a life sciences company that develops genomic insights for infectious diseases. Its core offering, the Karius Test, is a non-invasive blood test that sequences microbial cell-free DNA to identify and quantify pathogens—including bacteria, DNA viruses, fungi, and parasites—for use in complicated pneumonia, infections in immunocompromised patients, and endocarditis. The company also provides laboratory services for pathogen biomarker detection for biopharmaceutical research and development. Founded in 2014, Karius is headquartered in Redwood City, California, with an additional office in Menlo Park, California. The laboratory operations are CLIA-certified and CAP-accredited, enabling high-complexity clinical testing. By mapping a patient’s microbial landscape from a single blood draw, Karius aims to support rapid, informed treatment decisions.

Hippocratic AI

Series A in 2024
Hippocratic AI is a developer of safety-focused large language models designed for non-diagnostic, patient-facing applications within the healthcare sector. The company emphasizes the importance of evidence-based healthcare content, distinguishing itself from typical models that rely on a broader range of internet data, which may include inaccuracies. By prioritizing the acquisition of reliable healthcare information, Hippocratic AI aims to enhance healthcare accessibility and improve health outcomes. Its platform facilitates the delivery of healthcare services, allowing patients to receive care at home and manage their health more effectively and conveniently.

Eleanor Health

Venture Round in 2024
Eleanor Health is a provider of addiction and mental health services focused on delivering long-term recovery outcomes through a value-based care model. Founded in 2019 and headquartered in Waltham, Massachusetts, Eleanor offers comprehensive, whole-person care for mental health and substance misuse. The company operates a network of outpatient clinics and also provides virtual care as well as support in patients' homes and communities. Its services include medication-assisted treatment, evidence-based outpatient care, behavioral health services, and personalized recovery plans, all aimed at facilitating a faster recovery process for individuals suffering from substance abuse disorder.

Neko Health

Series A in 2023
Neko Health is a Swedish health-tech company focused on transforming healthcare through prevention and early detection. The company has developed innovative medical scanning technology that facilitates comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By utilizing advanced sensor technology and artificial intelligence, Neko Health aims to enhance preventive care and reduce the incidence of common diseases, thereby lowering associated healthcare costs. This approach enables healthcare providers to deliver flexible and cost-effective examinations, ultimately improving the quality of care and emphasizing the importance of preventive health measures.

Zageno

Venture Round in 2023
Zageno Inc. is an online retailer specializing in life science research products for scientists worldwide. Founded in 2015 and headquartered in Cambridge, Massachusetts, the company operates a comprehensive e-commerce platform that offers over 10 million products, including preparation items for protein purification and DNA extraction, gene editing tools, PCR reagents, sequencing kits, and various laboratory accessories. Zageno aims to streamline the procurement process for researchers by providing a user-friendly interface and a unique Scientific Score rating system that features unbiased, peer-reviewed evaluations of products. This approach enhances the purchasing experience, making it more efficient and reliable for life science professionals while also serving as an effective sales channel for suppliers. Additionally, Zageno has a presence in Berlin, Germany, further extending its reach in the scientific community.

Hippocratic AI

Seed Round in 2023
Hippocratic AI is a developer of safety-focused large language models designed for non-diagnostic, patient-facing applications within the healthcare sector. The company emphasizes the importance of evidence-based healthcare content, distinguishing itself from typical models that rely on a broader range of internet data, which may include inaccuracies. By prioritizing the acquisition of reliable healthcare information, Hippocratic AI aims to enhance healthcare accessibility and improve health outcomes. Its platform facilitates the delivery of healthcare services, allowing patients to receive care at home and manage their health more effectively and conveniently.

Memora Health

Venture Round in 2023
Memora Health is a San Francisco-based healthcare technology company that develops an intelligent care enablement platform to automate outpatient communication and digital workflows. The platform helps clinicians focus on top-of-license practice by digitizing and triaging patient-reported concerns and data, enabling proactive two-way communication and support for patients along complex care journeys, and it partners with health systems, health plans, and digital health companies to transform care delivery for care teams and patients.

CTRL Therapeutics

Seed Round in 2023
CTRL Therapeutics is a biotechnology company based in Toronto, Canada. It specializes in the research and development of cell therapies for treating cancerous tumors.

Paradigm

Series A in 2023
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.

Breathe Well-being

Series B in 2023
Breathe Well-being is a health technology company based in India. It offers a clinically proven program for individuals with chronic conditions like diabetes, aiming to help them lose weight and manage their health effectively. The program provides one-on-one coaching, tracking of weight, meals, and activity, along with cognitive behavioral therapy techniques to reduce stress.

Fay

Seed Round in 2023
Fay is a company focused on enhancing individual health through better nutrition by connecting clients with dietitians who are covered by their health insurance. It offers consulting services that specialize in medical nutrition therapy, facilitating access to personalized dietary guidance. Fay assists clients in selecting a suitable dietitian, coordinating both virtual and in-person consultations, and developing tailored nutrition plans. Additionally, the company collaborates with insurance providers to ensure that these services are affordable and accessible, thereby enabling individuals to receive comprehensive nutrition counseling that aligns with their health needs.

Disclo

Venture Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.

Maven Clinic

Series E in 2022
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Doccla

Series A in 2022
Doccla provides virtual ward services that move care from hospital to home through remote monitoring. A tech-agnostic partner to care organisations, it enables early discharge and reduces hospital readmissions by remotely monitoring patients with devices. Services include at-home onboarding with monitoring equipment, supported by a mobile team of nurses and doctors who conduct ongoing monitoring and manage offboarding as patients recover, delivering higher quality care at lower cost. The Covid-19 support service originated from NHS research and is deployed in collaboration with Northampton General Hospital.

Redesign Health

Series C in 2022
Founded in 2018, Redesign Health is a global venture builder empowering founders to launch and scale transformative healthcare companies. Since its inception, it has supported over two dozen companies impacting more than ten million lives across various healthcare sectors.

Homeward

Series B in 2022
Homeward delivers innovative rural health services for over 60 million Americans residing in rural communities. It employs multidisciplinary care teams offering both virtual and on-site care via mobile units, along with remote monitoring to enhance patient connections to high-quality, affordable healthcare.

August Health

Series A in 2022
August Health develops an integrated electronic health record platform for senior living communities. Their technology enables caregivers to shift from reactive to proactive care, offering features like digital move-ins, medication tracking, real-time insights, billing solutions, and mobile daily care tracking.

Examedi

Series A in 2022
Examedi is a healthcare startup that facilitates at-home medical services by connecting patients with independent healthcare providers, including nurses and lab technicians. The company's telemedicine platform allows patients to book diagnostic tests and examinations from the comfort of their homes, focusing on services such as blood tests, pregnancy tests, general check-ups, and COVID-19 testing. By streamlining the scheduling process and offering affordable access to various medical tests, Examedi aims to enhance patient convenience and improve healthcare delivery.

Flexpa

Seed Round in 2022
Flexpa is a healthcare technology company founded in 2021 and based in San Francisco, California. The company specializes in developing APIs that facilitate the integration of claims histories and diagnostic test data into digital health applications and fintech platforms. By digitizing and interpreting data collected from various hardware providers, Flexpa creates analytics dashboards that help healthcare providers monitor individual and population health outcomes. This enables more informed decision-making regarding treatment plans and pharmaceutical options for patients, ultimately aiming to enhance healthcare delivery and improve patient outcomes.

Orange Health Labs

Series B in 2022
Orange Health is a health technology company that facilitates remote diagnostic lab services for patients, allowing doctors to provide real-time care. Its platform focuses on patient-centric home sample collection and testing, aiming to make healthcare more accessible and efficient.

Osmind

Series B in 2022
Osmind Inc. is a San Francisco-based public benefit corporation founded in 2020 that specializes in developing healthcare software tailored for mental health providers and their patients. The company focuses on advancing evidence-based medicine to support individuals suffering from moderate to severe mental health conditions. Osmind's electronic health record platform is designed specifically for clinicians and researchers, facilitating interventional treatment workflows. It includes features such as journaling tools and support for health plan reimbursement, empowering healthcare professionals to implement innovative therapeutic approaches and precision psychiatry. By providing robust technology, Osmind aims to inform best practices in patient care and contribute to the development of new life-saving mental health treatments.

Eleanor Health

Series C in 2022
Eleanor Health is a provider of addiction and mental health services focused on delivering long-term recovery outcomes through a value-based care model. Founded in 2019 and headquartered in Waltham, Massachusetts, Eleanor offers comprehensive, whole-person care for mental health and substance misuse. The company operates a network of outpatient clinics and also provides virtual care as well as support in patients' homes and communities. Its services include medication-assisted treatment, evidence-based outpatient care, behavioral health services, and personalized recovery plans, all aimed at facilitating a faster recovery process for individuals suffering from substance abuse disorder.

Alinea Health

Venture Round in 2022
Alinea Health is a health-tech startup that provides solutions for corporate health. It utilizes large amounts of data and proprietary algorithms to assist the client company's beneficiaries in navigating their health plans, providing personalized and unbiased guidance, recommendations from the most effective doctors in the accredited network, and conveniences such as scheduling consultations and exams. In addition to continuous monitoring, its doctors use the Lifestyle Medicine methodology to promote a healthy lifestyle and lower the risk of developing chronic diseases.

Homeward

Series A in 2022
Homeward delivers innovative rural health services for over 60 million Americans residing in rural communities. It employs multidisciplinary care teams offering both virtual and on-site care via mobile units, along with remote monitoring to enhance patient connections to high-quality, affordable healthcare.

Story Health

Series A in 2022
Story Health Corporation is a healthcare technology company founded in 2020 and based in Saratoga, California. The company develops intelligent embedded virtualized clinical care software tools designed to assist healthcare specialists, including neurologists and primary care physicians, in understanding medical situations and making informed clinical decisions. Story Health's platform utilizes data from high-frequency sources to enhance therapy management through virtual protocols and adaptive machine learning. By focusing on patient-centered design, Story Health aims to bridge the gap between clinical evidence and real-world patient experiences, enabling clinicians to effectively address the physiological effects of disease and therapy.

Ro

Venture Round in 2022
Ro is a telehealth company founded in New York City in 2017. It operates digital health clinics for men's and women's health, smoking cessation, and offers a vertically integrated primary care platform that provides high-quality, affordable healthcare without the need for insurance.

Casana

Series B in 2022
Casana, officially known as Heart Health Intelligence Inc., is a healthcare technology company based in Rochester, New York, founded in 2018. It specializes in developing innovative solutions for heart health monitoring, primarily through its flagship product, the Heart Seat. This smart toilet seat is designed to facilitate effortless and continuous in-home health monitoring by capturing essential clinical measurements such as heart rate, blood pressure, cardiac output, ECG, and blood oxygenation. The Heart Seat integrates advanced sensors, including a single-lead ECG, embedded photoplethysmogram LEDs, and sensitive weight sensors, to monitor cardiac activity. By offering a cloud-connected platform, Casana enables healthcare practitioners to track patients' cardiac health beyond traditional clinical settings, thereby enhancing the management of chronic conditions and improving patient outcomes through reliable and consistent vital signs analysis.

Transcarent

Series C in 2022
Transcarent is a consumer-directed health and care platform serving employees of self-insured employers and their families. It combines software, technology, health guides, and data science to provide unbiased information, trusted guidance, and access to high-value care. The company connects users with an integrated ecosystem of high-value providers and health services, enabling customers to exercise choice and transparency for addressing a broad range of healthcare challenges.

The Breakaway

Seed Round in 2022
The Breakaway is a developer of a motivational coaching app specifically designed for fitness enthusiasts, with a primary focus on cyclists. The application offers users intelligent goal-setting and personalized insights to facilitate faster progress in their fitness journeys. Additionally, it provides motivational feedback and tips from professional athletes, ensuring that users remain engaged and informed as they work towards achieving their goals.

Well Dot

Series B in 2021
Well Dot, Inc. is a health technology company that builds an AI‑driven consumer‑health engagement platform and mobile application. The platform aggregates clinical and consumer data to tailor interactions that help users pursue health goals. It delivers personalized health guidance, actionable steps, and real‑time support from health professionals. Founded in 2019, the company is headquartered in Chapel Hill, North Carolina, with additional offices in Newton, Massachusetts; New York, New York; and Minneapolis, Minnesota.

Cadence Solutions

Series B in 2021
Cadence is a pioneering health technology company helping the nation’s largest health systems deliver world-class care outside of the four walls of the hospital.

Shyft

Seed Round in 2021
Shyft is a personalized wellness platform that offers guided nutrition, meditation, and yoga classes. Shyft offers a variety of Yoga based interactive classes and DIY content focused on managing specific conditions across women's health, chronic ailments, everyday wellness, and mental health.

Zageno

Series C in 2021
Zageno Inc. is an online retailer specializing in life science research products for scientists worldwide. Founded in 2015 and headquartered in Cambridge, Massachusetts, the company operates a comprehensive e-commerce platform that offers over 10 million products, including preparation items for protein purification and DNA extraction, gene editing tools, PCR reagents, sequencing kits, and various laboratory accessories. Zageno aims to streamline the procurement process for researchers by providing a user-friendly interface and a unique Scientific Score rating system that features unbiased, peer-reviewed evaluations of products. This approach enhances the purchasing experience, making it more efficient and reliable for life science professionals while also serving as an effective sales channel for suppliers. Additionally, Zageno has a presence in Berlin, Germany, further extending its reach in the scientific community.

Better Health

Series A in 2021
Better Health is a digital platform facilitating peer-to-peer support and supplies management for individuals with chronic conditions such as ostomy, wounds, diabetes, retention, and incontinence. Trusted by major healthcare payers and providers, it improves patient outcomes and reduces care costs through education, engagement, and adherence.

Sprinter Health

Series A in 2021
Sprinter Health is a mobile healthcare provider that sends full-time nurses and phlebotomists to patients' homes for preventive care services.

Orange Health Labs

Series A in 2021
Orange Health is a health technology company that facilitates remote diagnostic lab services for patients, allowing doctors to provide real-time care. Its platform focuses on patient-centric home sample collection and testing, aiming to make healthcare more accessible and efficient.

Breathe Well-being

Series A in 2021
Breathe Well-being is a health technology company based in India. It offers a clinically proven program for individuals with chronic conditions like diabetes, aiming to help them lose weight and manage their health effectively. The program provides one-on-one coaching, tracking of weight, meals, and activity, along with cognitive behavioral therapy techniques to reduce stress.

Athelas

Series B in 2021
Founded in 2002, Athelas develops and manufactures medical devices for remote patient monitoring. Its flagship product is an FDA-cleared blood diagnostic device that enables the detection of infections, inflammations, and malignancies. The company also offers sensors to monitor blood pressure, weight, glucose levels, and medication adherence.

Cadence Solutions

Series A in 2021
Cadence is a pioneering health technology company helping the nation’s largest health systems deliver world-class care outside of the four walls of the hospital.

SonderMind

Series C in 2021
SonderMind is a Denver-based digital health company established in 2017, specializing in accessible and approachable mental health services. It operates an online platform that connects individuals with a network of licensed therapists, offering a range of services including video telehealth and in-person sessions. SonderMind focuses on various mental health conditions such as anxiety, depression, ADHD, and PTSD, among others. The company aims to streamline the process of finding and accessing mental health care, ensuring a good match between clients and therapists, while also supporting therapists by handling administrative and billing tasks.

OM1

Series D in 2021
OM1 is a digital health company that provides an outcome management platform for healthcare organizations to measure, forecast, and compare patient outcomes. Its platform aggregates and analyzes clinical and patient-reported data to meet outcomes requirements in value-based care programs, CMS bundles, and private arrangements. The solution uses predictive and prescriptive analytics to identify risks, cost drivers, and opportunities to improve clinical and financial performance across the care continuum. By delivering AI-driven insights, OM1 helps hospitals and health systems demonstrate outcomes to stakeholders, support benchmarking and decision-making, and drive more precise care management. The company also maintains specialized registries for collaborations, including systemic lupus erythematosus, to support research and performance improvement. Through gathering and enriching diverse clinical data, OM1 aims to establish a higher standard for health outcomes information and enable more informed, value-based care.

Osana

Series A in 2021
Osana is a healthtech company offering an omnichannel platform focused on patient-centric care. This platform aims to optimize resource usage by providing services such as clinical analysis, emergency ambulance services, video consultations, and data-driven insights.

Osmind

Series A in 2021
Osmind Inc. is a San Francisco-based public benefit corporation founded in 2020 that specializes in developing healthcare software tailored for mental health providers and their patients. The company focuses on advancing evidence-based medicine to support individuals suffering from moderate to severe mental health conditions. Osmind's electronic health record platform is designed specifically for clinicians and researchers, facilitating interventional treatment workflows. It includes features such as journaling tools and support for health plan reimbursement, empowering healthcare professionals to implement innovative therapeutic approaches and precision psychiatry. By providing robust technology, Osmind aims to inform best practices in patient care and contribute to the development of new life-saving mental health treatments.

Transcarent

Series B in 2021
Transcarent is a consumer-directed health and care platform serving employees of self-insured employers and their families. It combines software, technology, health guides, and data science to provide unbiased information, trusted guidance, and access to high-value care. The company connects users with an integrated ecosystem of high-value providers and health services, enabling customers to exercise choice and transparency for addressing a broad range of healthcare challenges.

Terra API

Seed Round in 2021
Terra facilitates seamless health data exchange. It connects applications with various wearables, sensors, and blood labs.

Hallow

Series A in 2021
Hallow is a Catholic prayer and meditation app that hopes to help folks grow closer to God. It helps in finding peace, deepen the relationship with God, and sleeping soundly every night. It was founded in 2018 and is based in Chicago, Illinois.

Tempo

Series C in 2021
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.

Cityblock

Series C in 2021
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

Ro

Series D in 2021
Ro is a telehealth company founded in New York City in 2017. It operates digital health clinics for men's and women's health, smoking cessation, and offers a vertically integrated primary care platform that provides high-quality, affordable healthcare without the need for insurance.

Ossium Health

Series B in 2021
Ossium Health, Inc. is a biotechnology company that specializes in developing and manufacturing advanced cell therapy products aimed at treating blood cancers, improving organ transplantation, and repairing tissue damage caused by radiation exposure. Established in 2016 and based in San Francisco, the company has created a range of therapies, including HPC, Marrow, which consists of human leukocyte antigen (HLA)-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients. Additionally, Ossium offers Chimera, designed to enhance organ transplantation, and Chymalis, which utilizes mesenchymal stem cells from bone marrow to facilitate the healing of damaged bone and muscle tissue. The company also supplies bone marrow cells for research in oncology, immunology, and related fields, focusing on improving health and longevity through innovative bioengineering techniques.

Sprinter Health

Seed Round in 2021
Sprinter Health is a mobile healthcare provider that sends full-time nurses and phlebotomists to patients' homes for preventive care services.

Truvian Sciences

Series C in 2021
Truvian Sciences Inc. is a diagnostic company based in San Diego, California, focused on revolutionizing the blood testing industry. Incorporated in 2015, the company has developed an automated benchtop system that delivers lab-accurate results for a variety of health tests. Its comprehensive wellness panel includes commonly ordered routine blood tests such as complete blood count, metabolic panel, and lipid panel, all from a single sample. Additionally, Truvian's software system enables healthcare practitioners to efficiently deliver test results to patients through a user-friendly platform.

Casana

Series A in 2021
Casana, officially known as Heart Health Intelligence Inc., is a healthcare technology company based in Rochester, New York, founded in 2018. It specializes in developing innovative solutions for heart health monitoring, primarily through its flagship product, the Heart Seat. This smart toilet seat is designed to facilitate effortless and continuous in-home health monitoring by capturing essential clinical measurements such as heart rate, blood pressure, cardiac output, ECG, and blood oxygenation. The Heart Seat integrates advanced sensors, including a single-lead ECG, embedded photoplethysmogram LEDs, and sensitive weight sensors, to monitor cardiac activity. By offering a cloud-connected platform, Casana enables healthcare practitioners to track patients' cardiac health beyond traditional clinical settings, thereby enhancing the management of chronic conditions and improving patient outcomes through reliable and consistent vital signs analysis.

Elephant Healthcare

Series A in 2021
Founded by doctors in 2018, Elephant Healthcare is a London-based technology company dedicated to addressing global healthcare challenges. It designs and develops a digital health system that aims to connect all aspects of the healthcare ecosystem, transforming primary care, saving lives, and reducing costs.

Curai Health

Series B in 2020
Curai Health is a virtual care company founded in 2017 by Neal Khosla and Xavier Amatriain, headquartered in Palo Alto. The company specializes in providing affordable primary care through a chat-based interface that integrates artificial intelligence with human clinicians. This approach leverages advanced machine learning tools to streamline patient interactions and enhance diagnostic accuracy. By creating a responsive learning healthcare system, Curai Health aims to make high-quality primary care accessible to everyone, reducing the overall cost of care delivery. The service is available directly to consumers and can also be accessed through enterprise partnerships, emphasizing its commitment to improving healthcare accessibility and affordability.

Well Dot

Series A in 2020
Well Dot, Inc. is a health technology company that builds an AI‑driven consumer‑health engagement platform and mobile application. The platform aggregates clinical and consumer data to tailor interactions that help users pursue health goals. It delivers personalized health guidance, actionable steps, and real‑time support from health professionals. Founded in 2019, the company is headquartered in Chapel Hill, North Carolina, with additional offices in Newton, Massachusetts; New York, New York; and Minneapolis, Minnesota.

Cityblock

Series C in 2020
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

Story Health

Seed Round in 2020
Story Health Corporation is a healthcare technology company founded in 2020 and based in Saratoga, California. The company develops intelligent embedded virtualized clinical care software tools designed to assist healthcare specialists, including neurologists and primary care physicians, in understanding medical situations and making informed clinical decisions. Story Health's platform utilizes data from high-frequency sources to enhance therapy management through virtual protocols and adaptive machine learning. By focusing on patient-centered design, Story Health aims to bridge the gap between clinical evidence and real-world patient experiences, enabling clinicians to effectively address the physiological effects of disease and therapy.

Transcarent

Series A in 2020
Transcarent is a consumer-directed health and care platform serving employees of self-insured employers and their families. It combines software, technology, health guides, and data science to provide unbiased information, trusted guidance, and access to high-value care. The company connects users with an integrated ecosystem of high-value providers and health services, enabling customers to exercise choice and transparency for addressing a broad range of healthcare challenges.

Osmind

Seed Round in 2020
Osmind Inc. is a San Francisco-based public benefit corporation founded in 2020 that specializes in developing healthcare software tailored for mental health providers and their patients. The company focuses on advancing evidence-based medicine to support individuals suffering from moderate to severe mental health conditions. Osmind's electronic health record platform is designed specifically for clinicians and researchers, facilitating interventional treatment workflows. It includes features such as journaling tools and support for health plan reimbursement, empowering healthcare professionals to implement innovative therapeutic approaches and precision psychiatry. By providing robust technology, Osmind aims to inform best practices in patient care and contribute to the development of new life-saving mental health treatments.

Tempo

Series B in 2020
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.

Ro

Series C in 2020
Ro is a telehealth company founded in New York City in 2017. It operates digital health clinics for men's and women's health, smoking cessation, and offers a vertically integrated primary care platform that provides high-quality, affordable healthcare without the need for insurance.

SonderMind

Series B in 2020
SonderMind is a Denver-based digital health company established in 2017, specializing in accessible and approachable mental health services. It operates an online platform that connects individuals with a network of licensed therapists, offering a range of services including video telehealth and in-person sessions. SonderMind focuses on various mental health conditions such as anxiety, depression, ADHD, and PTSD, among others. The company aims to streamline the process of finding and accessing mental health care, ensuring a good match between clients and therapists, while also supporting therapists by handling administrative and billing tasks.

Karius

Series B in 2020
Karius is a life sciences company that develops genomic insights for infectious diseases. Its core offering, the Karius Test, is a non-invasive blood test that sequences microbial cell-free DNA to identify and quantify pathogens—including bacteria, DNA viruses, fungi, and parasites—for use in complicated pneumonia, infections in immunocompromised patients, and endocarditis. The company also provides laboratory services for pathogen biomarker detection for biopharmaceutical research and development. Founded in 2014, Karius is headquartered in Redwood City, California, with an additional office in Menlo Park, California. The laboratory operations are CLIA-certified and CAP-accredited, enabling high-complexity clinical testing. By mapping a patient’s microbial landscape from a single blood draw, Karius aims to support rapid, informed treatment decisions.

Elysium

Series C in 2019
Elysium Health, Inc., established in 2014 and headquartered in New York, specializes in the development and sale of health supplements. The company focuses on two primary areas: cellular health and optimization, and long-term brain health. It offers a proprietary formulation of natural compounds, designed to support overall well-being at the cellular level, which is sold directly to consumers via its online platform. Additionally, Elysium provides a biological age testing solution.

OM1

Series C in 2019
OM1 is a digital health company that provides an outcome management platform for healthcare organizations to measure, forecast, and compare patient outcomes. Its platform aggregates and analyzes clinical and patient-reported data to meet outcomes requirements in value-based care programs, CMS bundles, and private arrangements. The solution uses predictive and prescriptive analytics to identify risks, cost drivers, and opportunities to improve clinical and financial performance across the care continuum. By delivering AI-driven insights, OM1 helps hospitals and health systems demonstrate outcomes to stakeholders, support benchmarking and decision-making, and drive more precise care management. The company also maintains specialized registries for collaborations, including systemic lupus erythematosus, to support research and performance improvement. Through gathering and enriching diverse clinical data, OM1 aims to establish a higher standard for health outcomes information and enable more informed, value-based care.

Well Dot

Seed Round in 2019
Well Dot, Inc. is a health technology company that builds an AI‑driven consumer‑health engagement platform and mobile application. The platform aggregates clinical and consumer data to tailor interactions that help users pursue health goals. It delivers personalized health guidance, actionable steps, and real‑time support from health professionals. Founded in 2019, the company is headquartered in Chapel Hill, North Carolina, with additional offices in Newton, Massachusetts; New York, New York; and Minneapolis, Minnesota.

Zageno

Series B in 2019
Zageno Inc. is an online retailer specializing in life science research products for scientists worldwide. Founded in 2015 and headquartered in Cambridge, Massachusetts, the company operates a comprehensive e-commerce platform that offers over 10 million products, including preparation items for protein purification and DNA extraction, gene editing tools, PCR reagents, sequencing kits, and various laboratory accessories. Zageno aims to streamline the procurement process for researchers by providing a user-friendly interface and a unique Scientific Score rating system that features unbiased, peer-reviewed evaluations of products. This approach enhances the purchasing experience, making it more efficient and reliable for life science professionals while also serving as an effective sales channel for suppliers. Additionally, Zageno has a presence in Berlin, Germany, further extending its reach in the scientific community.

Curai Health

Series A in 2018
Curai Health is a virtual care company founded in 2017 by Neal Khosla and Xavier Amatriain, headquartered in Palo Alto. The company specializes in providing affordable primary care through a chat-based interface that integrates artificial intelligence with human clinicians. This approach leverages advanced machine learning tools to streamline patient interactions and enhance diagnostic accuracy. By creating a responsive learning healthcare system, Curai Health aims to make high-quality primary care accessible to everyone, reducing the overall cost of care delivery. The service is available directly to consumers and can also be accessed through enterprise partnerships, emphasizing its commitment to improving healthcare accessibility and affordability.

OM1

Series B in 2018
OM1 is a digital health company that provides an outcome management platform for healthcare organizations to measure, forecast, and compare patient outcomes. Its platform aggregates and analyzes clinical and patient-reported data to meet outcomes requirements in value-based care programs, CMS bundles, and private arrangements. The solution uses predictive and prescriptive analytics to identify risks, cost drivers, and opportunities to improve clinical and financial performance across the care continuum. By delivering AI-driven insights, OM1 helps hospitals and health systems demonstrate outcomes to stakeholders, support benchmarking and decision-making, and drive more precise care management. The company also maintains specialized registries for collaborations, including systemic lupus erythematosus, to support research and performance improvement. Through gathering and enriching diverse clinical data, OM1 aims to establish a higher standard for health outcomes information and enable more informed, value-based care.

Ro

Seed Round in 2017
Ro is a telehealth company founded in New York City in 2017. It operates digital health clinics for men's and women's health, smoking cessation, and offers a vertically integrated primary care platform that provides high-quality, affordable healthcare without the need for insurance.

OM1

Series A in 2017
OM1 is a digital health company that provides an outcome management platform for healthcare organizations to measure, forecast, and compare patient outcomes. Its platform aggregates and analyzes clinical and patient-reported data to meet outcomes requirements in value-based care programs, CMS bundles, and private arrangements. The solution uses predictive and prescriptive analytics to identify risks, cost drivers, and opportunities to improve clinical and financial performance across the care continuum. By delivering AI-driven insights, OM1 helps hospitals and health systems demonstrate outcomes to stakeholders, support benchmarking and decision-making, and drive more precise care management. The company also maintains specialized registries for collaborations, including systemic lupus erythematosus, to support research and performance improvement. Through gathering and enriching diverse clinical data, OM1 aims to establish a higher standard for health outcomes information and enable more informed, value-based care.

PatientBank

Seed Round in 2016
PatientBank is a medical information-sharing platform that facilitates the online request and management of medical records from various healthcare providers, including doctors and hospitals. The service enables patients to gather and store their medical records securely, allowing for easy sharing with care providers, hospitals, and family members. By streamlining the process of retrieving and sharing medical information, PatientBank enhances the efficiency of health checkups and improves communication between patients and their healthcare teams. The platform aims to empower individuals in managing their health information, making it more accessible when needed.

Elysium

Series B in 2016
Elysium Health, Inc., established in 2014 and headquartered in New York, specializes in the development and sale of health supplements. The company focuses on two primary areas: cellular health and optimization, and long-term brain health. It offers a proprietary formulation of natural compounds, designed to support overall well-being at the cellular level, which is sold directly to consumers via its online platform. Additionally, Elysium provides a biological age testing solution.

TearScience

Series D in 2016
TearScience, Inc. is a medical device company based in Morrisville, North Carolina, specializing in the identification, diagnosis, and treatment of meibomian gland disease (MGD), a primary cause of dry eye affecting millions worldwide. Founded in 2005, TearScience has developed innovative devices to address evaporative dry eye, including the LipiFlow Activator, which delivers automated therapeutic energies to treat the meibomian glands, and the LipiScan, an imaging tool that allows eye care professionals to assess gland health. The company's integrated system enables effective management of MGD, which is often underestimated despite being a leading contributor to dry eye symptoms such as irritation, dryness, and visual disturbances. As a subsidiary of Johnson & Johnson Surgical Vision, TearScience continues to advance its mission of improving patient outcomes through early detection and treatment of this chronic condition.

Oceans Healthcare

Venture Round in 2013
Oceans Healthcare is a behavioral health provider established in 2004, dedicated to healing and long-term recovery for individuals, particularly older adults. The company operates 33 locations, including 23 inpatient hospital campuses across the Southeast, and specializes in addressing cognitive and mental health symptoms such as depression, anxiety, and schizophrenia, as well as behavioral changes related to medication management and substance abuse. In 2020, Oceans treated over 18,000 individuals, demonstrating a commitment to comprehensive care throughout the recovery process. The company is recognized for its consistent achievement of high performance metrics on national quality and safety measurements, as assessed by the Centers for Medicare and Medicaid Services and The Joint Commission. Additionally, Oceans Healthcare has earned a place on the Inc. 5000 list of the fastest-growing private companies in America for four consecutive years.

SynapDx

Series B in 2012
SynapDx is a diagnostic company based in Lexington, Massachusetts, focused on providing laboratory testing services aimed at the early detection of autism spectrum disorders (ASDs) in children. Established by Stanley Lapidus, the company develops blood-based diagnostic tests that leverage insights from experts in ASD and gene expression. These tests are designed to assist healthcare providers in identifying early symptoms of autism, addressing the need for timely intervention in a condition that affects approximately 1 in 110 children in the United States. Through its innovative approach, SynapDx aims to enhance the diagnostic process for developmental disorders and improve outcomes for affected children and their families.

OvaScience

Series B in 2012
OvaScience, Inc. is a fertility company focused on discovering and commercializing innovative treatment options for women experiencing infertility. Founded in 2011 and headquartered in Waltham, Massachusetts, OvaScience developed proprietary technology based on the identification of egg precursor (EggPC) cells, enabling new approaches to fertility treatments. Its key offerings include OvaPrime, which aims to restore a woman's natural egg production by utilizing her own EggPC cells; OvaTure, which matures these cells into fertilizable eggs outside the body without hormone stimulation; and AUGMENT, which enhances fertilization and pregnancy rates using mitochondria from the woman’s EggPC cells. The company’s technology is exclusively licensed from Harvard Medical School and Massachusetts General Hospital, and it has been supported by a team of experts in reproductive science and embryology. OvaScience was initially known as Ovastem, Inc. before rebranding in 2011. In December 2018, OvaScience was acquired by Millendo Therapeutics, marking a significant shift in its operational focus.

Lose It!

Series A in 2012
Lose It! is a weight loss application designed to help individuals achieve and maintain a healthy weight. The platform allows users to set personalized weight loss goals and provides tools to track daily food intake and exercise. With a focus on community support, members can engage in competitive challenges and connect with others for motivation and accountability. The app generates tailored plans and calorie budgets based on individual health information and goals, utilizing a comprehensive database of food and exercise options. By combining proven nutritional science with user-friendly software, Lose It! aims to empower individuals to adopt healthier lifestyles and successfully reach their weight loss objectives.

SynapDx

Series A in 2010
SynapDx is a diagnostic company based in Lexington, Massachusetts, focused on providing laboratory testing services aimed at the early detection of autism spectrum disorders (ASDs) in children. Established by Stanley Lapidus, the company develops blood-based diagnostic tests that leverage insights from experts in ASD and gene expression. These tests are designed to assist healthcare providers in identifying early symptoms of autism, addressing the need for timely intervention in a condition that affects approximately 1 in 110 children in the United States. Through its innovative approach, SynapDx aims to enhance the diagnostic process for developmental disorders and improve outcomes for affected children and their families.

TearScience

Series C in 2010
TearScience, Inc. is a medical device company based in Morrisville, North Carolina, specializing in the identification, diagnosis, and treatment of meibomian gland disease (MGD), a primary cause of dry eye affecting millions worldwide. Founded in 2005, TearScience has developed innovative devices to address evaporative dry eye, including the LipiFlow Activator, which delivers automated therapeutic energies to treat the meibomian glands, and the LipiScan, an imaging tool that allows eye care professionals to assess gland health. The company's integrated system enables effective management of MGD, which is often underestimated despite being a leading contributor to dry eye symptoms such as irritation, dryness, and visual disturbances. As a subsidiary of Johnson & Johnson Surgical Vision, TearScience continues to advance its mission of improving patient outcomes through early detection and treatment of this chronic condition.

Lose It!

Seed Round in 2010
Lose It! is a weight loss application designed to help individuals achieve and maintain a healthy weight. The platform allows users to set personalized weight loss goals and provides tools to track daily food intake and exercise. With a focus on community support, members can engage in competitive challenges and connect with others for motivation and accountability. The app generates tailored plans and calorie budgets based on individual health information and goals, utilizing a comprehensive database of food and exercise options. By combining proven nutritional science with user-friendly software, Lose It! aims to empower individuals to adopt healthier lifestyles and successfully reach their weight loss objectives.

GTESS Corp

Series B in 2005
GTESS specializes in providing outsourced front-end solutions for the healthcare administrative services market. The company offers a range of services including claims conversion and cleaning, correspondence management, and coordination of benefits, which encompasses Medicare. By utilizing advanced artificial intelligence and neural network technology, GTESS enhances the efficiency of claims processing and document management. The company's solutions enable managed care organizations, third-party administrators, and health maintenance organizations to streamline their operations, reduce costs, and improve service quality. Through partnerships with leading healthcare payers and networks, GTESS aids its clients in focusing on strategic initiatives while positively impacting their financial performance.

GTESS Corp

Series A in 2004
GTESS specializes in providing outsourced front-end solutions for the healthcare administrative services market. The company offers a range of services including claims conversion and cleaning, correspondence management, and coordination of benefits, which encompasses Medicare. By utilizing advanced artificial intelligence and neural network technology, GTESS enhances the efficiency of claims processing and document management. The company's solutions enable managed care organizations, third-party administrators, and health maintenance organizations to streamline their operations, reduce costs, and improve service quality. Through partnerships with leading healthcare payers and networks, GTESS aids its clients in focusing on strategic initiatives while positively impacting their financial performance.

Sprinter Health

Sprinter Health is a mobile healthcare provider that sends full-time nurses and phlebotomists to patients' homes for preventive care services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.